Development of Shandong Ruiyang Pharmaceutical Co., Ltd.

First, a sound marketing network is the cornerstone of the steady development of Ruiyang Pharmaceutical.

Companies adhere to the market as the center, focusing on marketing. Innovate the first terminal sales model, increase the second and third terminal sales, improve the product and market planning ability, and build a reasonable and efficient marketing system. Implement "macro unified management and micro split control", introduce effective competition mechanism in management, and strictly honor rewards and punishments according to sales performance, so as to make product sales increase and market expand. At present, Ruiyang Company has more than 800 employees, and its products cover 100 cities in 29 provinces and cities across the country.

Second, the ability of continuous innovation is the source of the steady development of Ruiyang Pharmaceutical.

The investment in product development and technological innovation accounts for more than 3% of the total sales revenue, which provides reliable product guarantee for future development. In 2008, the company ranked 17 in the national hospital drug use ranking. At present, Ruiyang Company has successively obtained more than 40 patents and more than 60 new drug certificates. The annual output rate of new products is above 75%. The packaging level of penicillin semi-antibody powder injection, the extraction level of traditional Chinese medicine and the synthesis technology of cephalosporin raw materials have reached the leading level in China. Seven products, including Gegen decoction granules, mezlocillin sodium preparation for injection, bulk drug and mezlocillin sodium and sulbactam sodium for injection for injection, have passed the appraisal of scientific and technological achievements in Shandong Province. The new drug Gegen Tang Granule was recognized as "national key new product"; A new Chinese medicine, hydroxysafflor yellow A, was listed as a national 863 plan by the Ministry of Science and Technology.

At present, the company has three patented minute-needle powder loading equipment, the powder needle subpackaging capacity ranks in the top five in China, the freeze-drying product capacity is the largest in China, and the annual production capacity of sterile cephalosporin raw materials is 1000 tons, making it one of the largest production bases of cephalosporin raw materials in China. Relying on unique innovative technology, Ruiyang Company has the ability to produce a variety of products, which can meet the production needs of more than 30 kinds of products such as 5ml, 7ml, 8ml, 10ml, 12ml, 15ml, 18ml, 20ml and 32ml.

Third, a strict quality assurance system is the basis for the steady development of Ruiyang Pharmaceutical.

The internal control quality standard of Ruiyang pharmaceutical products is higher than the national standards such as China Pharmacopoeia. The company is responsible for drafting the national drug standards for mezlocillin sodium, Huasongshuan, Magnolia officinalis exhaust mixture and other 17 new drug products. Among them, mezlocillin sodium and potassium magnesium aspartate injection for injection were listed separately by the National Development and Reform Commission because their quality standards were higher than the national standards.

Fourth, the first-class information system is a bridge for the steady development of Ruiyang Pharmaceutical.

The total investment of Ruiyang Pharmaceutical Information System exceeds100000 yuan. On the gigabit backbone information platform, ERP (Enterprise Resource Planning), BPM (Project Process), HR (Human Resources), TPI (Digital Library) management system, video monitoring and VOIP (Internet Phone) telephone system have been implemented successively. At present, the company's overall information management level is in a leading position in China.

In recent years, the company has been recognized as a national key high-tech enterprise, a national torch plan key project enterprise, a national biomedical industrialization key enterprise, a national 863 plan achievement industrialization base key enterprise, a national Post-Doctoral Research Center, a national contract-abiding and credit-abiding enterprise, a key support enterprise of the Ministry of Commerce, and a Shandong star enterprise with China patent. "Ruiyang" trademark was recognized as a well-known trademark in China.